https://news.medxy.ai/zh/bioadhesive-toothpaste-reduces-enamel-erosion/Medxy AIzh2026-11-14T04:41:49-08:00生物黏附性聚合物牙膏：应对牙釉质酸蚀与磨耗的新策略 https://news.medxy.ai/ja/bioadhesive-polymer-toothpastes-emerging-strategies/Medxy AIja2026-11-14T04:41:32-08:00生体接着性ポリマー配合歯磨剤：エナメル質の浸食および摩耗に対する新たな対策戦略 https://news.medxy.ai/vi/bioadhesive-polymer-toothpastes-emerging-strategies-against-enamel-erosion-abrasion/Medxy AIvi2026-11-14T04:41:12-08:00Kem đánh răng chứa polymer có khả năng bám dính sinh học: Các chiến lược mới nhằm chống lại tình trạng xói mòn và mài mòn men răng https://news.medxy.ai/bioadhesive-polymer-toothpastes-emerging-strategies-against-enamel-erosion-and-abrasion/Medxy AIen2026-11-14T04:40:58-08:00Bioadhesive Polymer Toothpastes: Emerging Strategies Against Enamel Erosion and Abrasion https://news.medxy.ai/zh/cangrelor-versus-crushed-ticagrelor-in-acute-myocardial-infarction-with-cardiogenic-shock/Medxy AIzh2026-11-14T04:40:23-08:00在合并心源性休克的急性心肌梗死患者中，坎格雷洛（Cangrelor）与研碎的替格瑞洛（Ticagrelor）的对比研究（DAPT-SHOCK-AMI） https://news.medxy.ai/ja/cangrelor-versus-crushed-ticagrelor-in-acute-myocardial-infarction-cardiogenic-shock/Medxy AIja2026-11-14T04:40:03-08:00心原性ショックを合併した急性心筋梗塞におけるカングレロールと粉砕したチカグレロルの比較（DAPT-SHOCK-AMI）：無作為化二重盲検試験 https://news.medxy.ai/vi/cangrelor-versus-crushed-ticagrelor-in-acute-myocardial-infarction-complicated-by-cardiogenic-shock/Medxy AIvi2026-11-14T04:39:42-08:00So sánh cangrelor với ticagrelor dạng nghiền trong nhồi máu cơ tim cấp có biến chứng sốc tim (DAPT-SHOCK-AMI): một thử nghiệm ngẫu nhiên, mù đôi https://news.medxy.ai/cangrelor-versus-crushed-ticagrelor-in-acute-myocardial-infarction-complicated-by-cardiogenic-shock-insights-from-the-dapt-shock-ami-randomised-double-blind-trial/Medxy AIen2026-11-14T04:39:23-08:00Cangrelor versus Crushed Ticagrelor in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the DAPT-SHOCK-AMI Randomised, Double-Blind Trial https://news.medxy.ai/zh/staph-bloodstream-infections-children/Medxy AIzh2026-11-14T04:38:31-08:00儿科肿瘤中金黄色葡萄球菌血流感染的管理优化：中心静脉导管拔除为何至关重要 https://news.medxy.ai/ja/staphylococcal-bacteremia-management/Medxy AIja2026-11-14T04:38:11-08:00小児腫瘍における黄色ブドウ球菌血流感染症の管理最適化：中心静脈カテーテル抜去の決定的意義 https://news.medxy.ai/vi/optimizing-staph-aureus-sepsis-management/Medxy AIvi2026-11-14T04:37:52-08:00Tối ưu hóa xử trí nhiễm khuẩn huyết do Staphylococcus aureus ở bệnh nhi ung thư: Vai trò then chốt của việc rút ống thông tĩnh mạch trung tâm https://news.medxy.ai/optimizing-management-of-staphylococcus-aureus-bloodstream-infections-in-pediatric-oncology-the-crucial-role-of-central-venous-catheter-removal/Medxy AIen2026-11-14T04:37:36-08:00Optimizing Management of Staphylococcus aureus Bloodstream Infections in Pediatric Oncology: The Crucial Role of Central Venous Catheter Removal https://news.medxy.ai/ja/memantine-lupus-trial/Medxy AIja2026-11-14T04:37:01-08:00全身性エリテマトーデス患者におけるメマンチンの神経心理学的機能改善効果：第2相ランダム化プラセボ対照臨床試験 https://news.medxy.ai/vi/memantine-improves-neuropsychological-function/Medxy AIvi2026-11-14T04:36:44-08:00Memantine giúp cải thiện chức năng thần kinh – tâm lý ở bệnh nhân ban đỏ hệ thống: thử nghiệm lâm sàng pha 2 ngẫu nhiên, đối chứng giả dược https://news.medxy.ai/improvement-in-neuropsychological-function-with-memantine-treatment-among-patients-with-systemic-lupus-erythematosus-a-phase-2-randomised-placebo-controlled-clinical-trial/Medxy AIen2026-11-14T04:36:30-08:00Improvement in Neuropsychological Function with Memantine Treatment Among Patients with Systemic Lupus Erythematosus: A Phase 2 Randomised Placebo-Controlled Clinical Trial https://news.medxy.ai/zh/kidney-transplant-rejection-treatment/Medxy AIzh2026-11-14T04:35:56-08:00整合分子诊断与供者来源游离DNA，优化肾移植T细胞介导排斥反应的治疗 https://news.medxy.ai/ja/kidney-transplant-rejection-diagnostics/Medxy AIja2026-11-14T04:35:40-08:00腎移植におけるT細胞介在性拒絶反応の最適化へ向けた分子診断とドナー由来cell-free DNAの統合 https://news.medxy.ai/vi/molecular-diagnostics-transplant-rejection/Medxy AIvi2026-11-14T04:35:21-08:00Kết hợp chẩn đoán phân tử và dd-cfDNA để tối ưu điều trị thải ghép qua trung gian tế bào T ở ghép thận https://news.medxy.ai/zh/oral-estrogen-porphyria/Medxy AIzh2026-11-14T04:34:20-08:00口服雌激素治疗与迟发性皮肤卟啉病：来自丹麦全国性研究的启示 https://news.medxy.ai/ja/oral-estrogen-porphyria-2/Medxy AIja2026-11-14T04:34:03-08:00経口エストロゲン療法は肝性皮膚ポルフィリン症のリスクを高めるのか：デンマーク全国研究が示す知見 https://news.medxy.ai/vi/oral-estrogen-porphyria-3/Medxy AIvi2026-11-14T04:33:45-08:00Liệu pháp estrogen đường uống có làm tăng nguy cơ mắc bệnh porphyria da do gan không? Những phát hiện từ một nghiên cứu trên toàn quốc tại Đan Mạch https://news.medxy.ai/oral-estrogen-therapy-and-its-association-with-porphyria-cutanea-tarda-insights-from-a-danish-nationwide-study/Medxy AIen2026-11-14T04:33:31-08:00Oral Estrogen Therapy and Its Association with Porphyria Cutanea Tarda: Insights from a Danish Nationwide Study https://news.medxy.ai/zh/improved-tongue-reconstruction/Medxy AIzh2026-11-14T04:32:53-08:00改良个体化深深动脉穿支皮瓣模型：提升全舌重建的功能与美学效果 https://news.medxy.ai/ja/improved-tongue-reconstructions/Medxy AIja2026-11-14T04:32:38-08:00改良型個別化深穿通枝皮弁モデル：全舌再建における機能的・審美的効果の向上 https://news.medxy.ai/vi/improved-tongue-reconstruction-2/Medxy AIvi2026-11-14T04:32:19-08:00Cải thiện rõ rệt chức năng và thẩm mỹ trong tái tạo toàn bộ lưỡi bằng mô hình vạt xuyên động mạch đùi sâu cá thể hóa cải tiến https://news.medxy.ai/enhanced-functional-and-aesthetic-outcomes-in-total-tongue-reconstruction-using-a-modified-individualized-profunda-artery-perforator-flap-model/Medxy AIen2026-11-14T04:32:05-08:00Enhanced Functional and Aesthetic Outcomes in Total Tongue Reconstruction Using a Modified Individualized Profunda Artery Perforator Flap Model https://news.medxy.ai/ja/standardizing-ventilator-weaning-trials/Medxy AIja2026-11-14T04:31:24-08:00急性脳損傷における人工呼吸器離脱試験の評価項目を標準化：国際Delphiが合意形成 https://news.medxy.ai/vi/standardizing-ventilation-weaning-outcomes/Medxy AIvi2026-11-14T04:30:57-08:00Chuẩn hóa kết cục trong thử nghiệm cai thở máy ở tổn thương não cấp tính: đồng thuận Delphi quốc tế đạt nhất trí https://news.medxy.ai/zh/acute-brain-injury-consensus/Medxy AIzh2026-11-14T04:30:30-08:00急性脑损伤通气试验结局如何统一：国际Delphi达成首个共识 https://news.medxy.ai/standardizing-outcomes-for-ventilation-trials-in-acute-brain-injury-an-international-delphi-reaches-consensus/Medxy AIen2026-11-14T04:30:11-08:00Standardizing Outcomes for Ventilation Trials in Acute Brain Injury: An International Delphi Reaches Consensus https://news.medxy.ai/zh/evolving-chest-pain-management/Medxy AIzh2026-11-14T04:29:15-08:00急诊胸痛无心肌梗死患者管理的演变趋势：对临床实践与结局的启示 https://news.medxy.ai/ja/emergency-chest-pain-management/Medxy AIja2026-11-14T04:28:57-08:00胸痛患者の救急外来管理はどう変わったか：心筋梗塞を伴わない症例の診療動向と転帰 https://news.medxy.ai/vi/chest-pain-emergency-care/Medxy AIvi2026-11-14T04:28:38-08:00Xu hướng mới trong xử trí đau ngực tại khoa cấp cứu: không có nhồi máu cơ tim thì nên thay đổi thực hành và kết cục ra sao? https://news.medxy.ai/evolving-trends-in-emergency-department-management-of-chest-pain-without-myocardial-infarction-implications-for-practice-and-outcomes/Medxy AIen2026-11-14T04:28:20-08:00Evolving Trends in Emergency Department Management of Chest Pain Without Myocardial Infarction: Implications for Practice and Outcomes https://news.medxy.ai/zh/covid-impact-lung-cancer-screening/Medxy AIzh2026-11-14T04:27:46-08:00COVID-19 疫情对美国退伍军人肺癌筛查与诊断的影响：一项涵盖 2017—2023 年的队列研究 https://news.medxy.ai/ja/covid-19-lung-cancer-screening-impact/Medxy AIja2026-11-14T04:27:27-08:00COVID-19パンデミックが米国退役軍人の肺がんスクリーニングと診断に及ぼした影響：2017～2023年の包括的コホート研究 https://news.medxy.ai/vi/covid-19-lung-cancer-screening/Medxy AIvi2026-11-14T04:27:10-08:00Tác động của đại dịch COVID-19 đối với việc sàng lọc và chẩn đoán ung thư phổi ở các cựu chiến binh Hoa Kỳ: Nghiên cứu đoàn hệ toàn diện giai đoạn 2017–2023 https://news.medxy.ai/impact-of-the-covid-19-pandemic-on-lung-cancer-screening-and-diagnosis-among-us-veterans-a-comprehensive-cohort-study-2017-2023/Medxy AIen2026-11-14T04:26:54-08:00Impact of the COVID-19 Pandemic on Lung Cancer Screening and Diagnosis Among US Veterans: A Comprehensive Cohort Study (2017-2023) https://news.medxy.ai/zh/genomic-diagnostics-for-bone-marrow-failure/Medxy AIzh2026-11-14T04:26:13-08:00前置全基因组与转录组测序：提升遗传性骨髓衰竭综合征诊断的新路径 https://news.medxy.ai/ja/genomic-diagnostics-bone-marrow-failure/Medxy AIja2026-11-14T04:25:56-08:00全ゲノムおよびトランスクリプトーム解析の先行実施：遺伝性骨髄不全症候群の診断を向上させる新たなアプローチ https://news.medxy.ai/vi/genomic-diagnostics-in-bone-marrow-failure/Medxy AIvi2026-11-14T04:25:39-08:00Giải trình tự toàn bộ hệ gen và hệ phiên mã ngay từ bước đầu: Hướng đi mới nhằm cải thiện chẩn đoán các hội chứng suy tủy xương di truyền https://news.medxy.ai/enhancing-diagnosis-in-inherited-bone-marrow-failure-syndromes-with-upfront-whole-genome-and-transcriptome-sequencing/Medxy AIen2026-11-14T04:25:23-08:00Enhancing Diagnosis in Inherited Bone Marrow Failure Syndromes with Upfront Whole Genome and Transcriptome Sequencing https://news.medxy.ai/zh/systemic-inflammation-bronchiectasis/Medxy AIzh2026-11-14T04:24:47-08:00全身性中性粒细胞炎症推动支气管扩张症严重程度与急性加重风险：EMBARC-BRIDGE 研究启示 https://news.medxy.ai/ja/systemic-neutrophilic-inflammation-brochiectasis-exacerbation/Medxy AIja2026-11-14T04:24:33-08:00全身性の好中球性炎症が気管支拡張症の重症度と急性増悪リスクを促進する：EMBARC-BRIDGE研究からの示唆 https://news.medxy.ai/vi/systemic-neutrophilic-inflammation-brochiectasis-exacerbations/Medxy AIvi2026-11-14T04:23:38-08:00Viêm bạch cầu trung tính toàn thân thúc đẩy mức độ nặng và nguy cơ đợt cấp của giãn phế quản: Phát hiện từ nghiên cứu EMBARC-BRIDGE https://news.medxy.ai/systemic-neutrophilic-inflammation-drives-bronchiectasis-severity-and-exacerbation-risk-insights-from-the-embarc-bridge-study/Medxy AIen2026-11-14T04:23:24-08:00Systemic Neutrophilic Inflammation Drives Bronchiectasis Severity and Exacerbation Risk: Insights from the EMBARC-BRIDGE Study https://news.medxy.ai/zh/adult-strabismus-care-access/Medxy AIzh2026-11-14T04:22:45-08:00美国成人斜视诊疗可及性差异：全国视角下的公平治疗启示 https://news.medxy.ai/ja/addressing-adult-strabismus-care-disparities/Medxy AIja2026-11-14T04:22:26-08:00成人斜視診療の受療格差をどう解消するか：米国全国データが示す課題と公平な医療提供への示唆 https://news.medxy.ai/bariatric-surgery-as-an-effective-salvage-approach-following-semaglutide-or-tirzepatide-therapy-failure/Medxy AIen2026-11-14T04:22:13-08:00Bariatric Surgery as an Effective Salvage Approach Following Semaglutide or Tirzepatide Therapy Failure https://news.medxy.ai/vi/addressing-adult-strabismus-care-disparities-access/Medxy AIvi2026-11-14T04:22:05-08:00Sự chênh lệch trong khả năng tiếp cận dịch vụ chăm sóc bệnh lác ở người trưởng thành tại Hoa Kỳ: Những hàm ý về sự công bằng trong điều trị dưới góc nhìn quốc gia https://news.medxy.ai/potential-disparities-in-access-to-adult-strabismus-care-a-national-perspective-and-implications-for-equitable-treatment/Medxy AIen2026-11-14T04:21:48-08:00Potential Disparities in Access to Adult Strabismus Care: A National Perspective and Implications for Equitable Treatment https://news.medxy.ai/ja/submandibular-gland-cancer-selective-neck-dissection/Medxy AIja2026-11-14T04:20:48-08:00臨床的にリンパ節転移を認めない顎下腺癌に対し、選択的頸部郭清術は必要か？――生存上の利益と手術の意思決定に関する考察 https://news.medxy.ai/vi/selective-neck-dissection/Medxy AIvi2026-11-14T04:20:28-08:00Phẫu tích cổ chọn lọc trong ung thư tuyến dưới hàm cN0: lợi ích sống còn và hàm ý cho quyết định phẫu thuật https://news.medxy.ai/evaluating-elective-neck-dissection-in-clinically-node-negative-submandibular-gland-cancer-implications-for-survival-and-surgical-decision-making/Medxy AIen2026-11-14T04:20:13-08:00Evaluating Elective Neck Dissection in Clinically Node-Negative Submandibular Gland Cancer: Implications for Survival and Surgical Decision-Making https://news.medxy.ai/zh/acs-certification-improves-surgical-outcomes/Medxy AIzh2026-11-14T04:19:36-08:00ACS认证助力急诊普通外科结局改善：来自验证项目的启示 https://news.medxy.ai/ja/acs-certification-improves-outcomes/Medxy AIja2026-11-14T04:19:23-08:00ACS認証が救急一般外科の成績を改善——注目される質向上効果 https://news.medxy.ai/vi/improving-emergency-surgery-outcomes/Medxy AIvi2026-11-14T04:19:07-08:00Nâng cao kết cục phẫu thuật tổng quát cấp cứu: Những phát hiện từ Chương trình Xác minh của ACS https://news.medxy.ai/enhancing-emergency-general-surgery-outcomes-insights-from-the-acs-verification-program/Medxy AIen2026-11-14T04:18:53-08:00Enhancing Emergency General Surgery Outcomes: Insights from the ACS Verification Program https://news.medxy.ai/zh/minimally-invasive-vs-open-hysterectomy/Medxy AIzh2026-11-14T04:18:19-08:00低风险宫颈癌中微创手术与开腹根治性子宫切除术：对肿瘤学结局的不同影响 https://news.medxy.ai/ja/minimally-invasive-vs-open-hysterectomy-3/Medxy AIja2026-11-14T04:18:02-08:00低リスク子宮頸がんにおける低侵襲手術と開腹根治的子宮全摘術：腫瘍学的転帰への影響の差異 https://news.medxy.ai/vi/minimally-invasive-vs-open-hysterectomy-2/Medxy AIvi2026-11-14T04:17:44-08:00Cắt tử cung triệt căn xâm lấn tối thiểu hay phẫu thuật mở trong ung thư cổ tử cung nguy cơ thấp: Khác biệt về kết cục ung bướu https://news.medxy.ai/minimally-invasive-surgery-vs-open-radical-hysterectomy-in-low-risk-cervical-cancer-differential-impact-on-oncologic-outcomes/Medxy AIen2026-11-14T04:17:28-08:00Minimally Invasive Surgery vs Open Radical Hysterectomy in Low-Risk Cervical Cancer: Differential Impact on Oncologic Outcomes https://news.medxy.ai/zh/targeting-myeloid-cd36/Medxy AIzh2026-11-14T04:16:48-08:00靶向髓系CD36增强巨噬细胞介导免疫：抗肝纤维化的新策略 https://news.medxy.ai/ja/targeting-cd36-liver-fibrosis/Medxy AIja2026-11-14T04:16:31-08:00マクロファージ免疫を高めるための骨髄系CD36標的化：肝線維化に対する新たな戦略 https://news.medxy.ai/vi/targeting-cd36-liver-fibrosis-2/Medxy AIvi2026-11-14T04:16:13-08:00Nhắm đích CD36 trên dòng tủy: hướng đi mới tăng cường miễn dịch của đại thực bào trong xơ hóa gan https://news.medxy.ai/targeting-myeloid-cd36-to-enhance-macrophage-mediated-immunity-a-novel-strategy-against-hepatic-fibrosis/Medxy AIen2026-11-14T04:15:56-08:00Targeting Myeloid CD36 to Enhance Macrophage-Mediated Immunity: A Novel Strategy Against Hepatic Fibrosis https://news.medxy.ai/zh/atrial-fibrillation-anticoagulation-risks/Medxy AIzh2026-11-14T04:15:18-08:00心房颤动合并既往颅内出血：抗凝治疗如何权衡获益与风险？ https://news.medxy.ai/ja/blance-between-atrial-fibrillation-anticoagulation-risks/Medxy AIja2026-11-14T04:15:03-08:00心房細動と頭蓋内出血の既往：抗凝固療法におけるベネフィットとリスクの天秤をどう考えるか？ https://news.medxy.ai/vi/balancing-anticoagulation-risks-benefits/Medxy AIvi2026-11-14T04:14:46-08:00Cân bằng nguy cơ và lợi ích: chiến lược chống đông ở bệnh nhân rung nhĩ có tiền sử chảy máu nội sọ https://news.medxy.ai/balancing-risks-and-benefits-anticoagulation-strategies-in-atrial-fibrillation-patients-with-prior-intracranial-bleeding/Medxy AIen2026-11-14T04:14:29-08:00Balancing Risks and Benefits: Anticoagulation Strategies in Atrial Fibrillation Patients With Prior Intracranial Bleeding https://news.medxy.ai/zh/ras-positive-thyroid-nodules/Medxy AIzh2026-11-14T04:13:51-08:00RAS阳性甲状腺结节风险分层再优化：大型手术队列的临床与分子学启示 https://news.medxy.ai/ja/reassessing-ras-positive-thyroid-nodules/Medxy AIja2026-11-14T04:13:35-08:00RAS陽性甲状腺結節のリスク層別化を再考する：大規模外科コホートからみた臨床・分子学的知見 https://news.medxy.ai/vi/risk-stratification-ras-positive-thyroid-nodules/Medxy AIvi2026-11-14T04:13:18-08:00Tinh chỉnh phân tầng nguy cơ ở nhân giáp dương tính với RAS: Những phát hiện lâm sàng và phân tử từ một đoàn hệ phẫu thuật lớn https://news.medxy.ai/refining-risk-stratification-in-ras-positive-thyroid-nodules-clinical-and-molecular-insights-from-a-large-surgical-cohort/Medxy AIen2026-11-14T04:13:02-08:00Refining Risk Stratification in RAS-Positive Thyroid Nodules: Clinical and Molecular Insights from a Large Surgical Cohort https://news.medxy.ai/ja/dapagliflozin-kidney-function/Medxy AIja2026-11-14T04:12:09-08:00心移植後の腎機能を支えるダパグリフロジン：DAPARHT試験が示した新知見 https://news.medxy.ai/vi/dapagliflozin-improves-kidney-function/Medxy AIvi2026-11-14T04:11:51-08:00Dapagliflozin giúp cải thiện chức năng thận ở người nhận ghép tim: Những phát hiện từ thử nghiệm DAPARHT https://news.medxy.ai/dapagliflozin-enhances-renal-function-in-heart-transplant-recipients-insights-from-the-daparht-trial/Medxy AIen2026-11-14T04:11:37-08:00Dapagliflozin Enhances Renal Function in Heart Transplant Recipients: Insights from the DAPARHT Trial https://news.medxy.ai/zh/hb0025-chemotherapy-lung-cancer/Medxy AIzh2026-11-14T04:11:02-08:00HB0025联合化疗治疗晚期非小细胞肺癌显示前景：来自Ⅱ期试验的研究解读 https://news.medxy.ai/ja/promising-lung-cancer-combination/Medxy AIja2026-11-14T04:10:47-08:00進行非小細胞肺癌にHB0025併用療法が有望：第2相試験から見えた可能性 https://news.medxy.ai/vi/hb0025-chemotherapy-nsclc-advanced/Medxy AIvi2026-11-14T04:10:29-08:00HB0025 phối hợp hóa trị cho thấy triển vọng trong điều trị ung thư phổi không tế bào nhỏ tiến triển: Góc nhìn từ thử nghiệm pha 2 https://news.medxy.ai/hb0025-plus-chemotherapy-shows-promise-in-treating-advanced-non-small-cell-lung-cancer-insights-from-a-phase-2-trial/Medxy AIen2026-11-14T04:10:14-08:00HB0025 Plus Chemotherapy Shows Promise in Treating Advanced Non-Small Cell Lung Cancer: Insights From a Phase 2 Trial https://news.medxy.ai/zh/hip-arthroscopy-capsulotomy-results-2/Medxy AIzh2026-11-14T04:09:35-08:00髋关节镜手术中的多入路法与T形关节囊切开术：现代临床实践中疗效与存活率相当 https://news.medxy.ai/ja/hip-arthroscopy-capsulotomy/Medxy AIja2026-11-14T04:09:18-08:00股関節鏡視下手術におけるインターポータル法とT字型カプスロトミー：現代診療で同等の転帰と生存率 https://news.medxy.ai/vi/hip-arthroscopy-capsulotomy-results/Medxy AIvi2026-11-14T04:09:00-08:00Capsulotomy interportal hay T-type trong nội soi khớp háng: Kết quả và khả năng sống còn tương đương trong thực hành hiện nay https://news.medxy.ai/interportal-vs-t-type-capsulotomy-in-hip-arthroscopy-equivalent-outcomes-and-survivorship-in-contemporary-practice/Medxy AIen2026-11-14T04:08:45-08:00Interportal vs. T-Type Capsulotomy in Hip Arthroscopy: Equivalent Outcomes and Survivorship in Contemporary Practice https://news.medxy.ai/zh/combined-rehabilitation-stroke-dementia/Medxy AIzh2026-11-14T04:08:04-08:00联合物理与认知康复可降低卒中后痴呆风险：一项美国多中心回顾性队列研究的启示 https://news.medxy.ai/ja/combined-rehabilitation-reduces-dementia-risk/Medxy AIja2026-11-14T04:07:48-08:00身体と認知を組み合わせたリハビリで脳卒中後認知症リスクが低下：米国多施設後ろ向きコホート研究からの知見 https://news.medxy.ai/vi/cognitive-physical-rehabilitation-stroke-dementia/Medxy AIvi2026-11-14T04:07:28-08:00Phục hồi chức năng thể chất kết hợp nhận thức giúp giảm nguy cơ sa sút trí tuệ sau đột quỵ: Góc nhìn từ nghiên cứu đoàn hệ hồi cứu đa trung tâm tại Hoa Kỳ https://news.medxy.ai/combined-physical-and-cognitive-rehabilitation-reduces-poststroke-dementia-risk-insights-from-a-us-multicenter-retrospective-cohort-study/Medxy AIen2026-11-14T04:07:11-08:00Combined Physical and Cognitive Rehabilitation Reduces Poststroke Dementia Risk: Insights from a US Multicenter Retrospective Cohort Study https://news.medxy.ai/zh/keratinized-mucosa-dental-implant-outcomes/Medxy AIzh2026-11-14T04:06:35-08:00角化黏膜宽度与黏膜厚度对牙种植体稳定性及患者舒适度的长期影响：一项25年队列研究 https://news.medxy.ai/ja/keratinized-mucosa-implant-stability/Medxy AIja2026-11-14T04:06:16-08:00角化粘膜幅と粘膜厚さはインプラントの安定性と患者の快適性にどう影響するか：25年間コホート研究から見えてきたこと https://news.medxy.ai/vi/long-term-implant-stability/Medxy AIvi2026-11-14T04:05:36-08:00Tác động lâu dài của chiều rộng niêm mạc sừng hóa và độ dày niêm mạc đối với độ ổn định implant nha khoa và sự thoải mái của người bệnh: Bằng chứng từ nghiên cứu thuần tập 25 năm https://news.medxy.ai/long-term-impact-of-keratinized-mucosa-width-and-mucosal-thickness-on-dental-implant-stability-and-patient-comfort-insights-from-a-25-year-cohort-study/Medxy AIen2026-11-14T04:05:19-08:00Long-Term Impact of Keratinized Mucosa Width and Mucosal Thickness on Dental Implant Stability and Patient Comfort: Insights from a 25-Year Cohort Study https://news.medxy.ai/zh/silent-atherosclerosis-prevalence/Medxy AIzh2026-11-14T04:04:36-08:00成年期静默性动脉粥样硬化的患病率：流行病学、危险因素与血管分布的综合综述 https://news.medxy.ai/ja/silent-atherosclerosis-prevalence-in-adult/Medxy AIja2026-11-14T04:04:14-08:00成人期における無症候性動脈硬化の有病率：疫学、危険因子、および血管分布に関する包括的レビュー https://news.medxy.ai/vi/silent-atherosclerosis-prevalence-2/Medxy AIvi2026-11-14T04:03:48-08:00Tỷ lệ hiện mắc xơ vữa động mạch im lặng suốt vòng đời trưởng thành: tổng quan tích hợp về dịch tễ học, yếu tố nguy cơ và phân bố mạch máu https://news.medxy.ai/prevalence-of-silent-atherosclerosis-across-adult-life-an-integrative-review-of-epidemiology-risk-factors-and-vascular-distribution/Medxy AIen2026-11-14T04:03:27-08:00Prevalence of Silent Atherosclerosis across Adult Life: An Integrative Review of Epidemiology, Risk Factors, and Vascular Distribution https://news.medxy.ai/zh/post-stroke-arm-assessment/Medxy AIzh2026-11-13T04:01:03-08:00卒中后上肢评估新进展：FULMA单摄像头无标记动作捕捉系统 https://news.medxy.ai/ja/stroke-assessment-fulma/Medxy AIja2026-11-13T04:00:47-08:00脳卒中後上肢評価を前進させる：単一カメラ・マーカーレス動作解析システムFULMA https://news.medxy.ai/vi/upper-limb-stroke-assessment/Medxy AIvi2026-11-13T04:00:29-08:00Đánh giá chi trên sau đột quỵ tiến một bước: hệ thống chụp bắt chuyển động không gắn mốc dùng một camera FULMA https://news.medxy.ai/advancing-post-stroke-upper-limb-assessment-the-fulma-single-camera-markerless-motion-capture-system/Medxy AIen2026-11-13T04:00:13-08:00Advancing Post-Stroke Upper Limb Assessment: The FULMA Single-Camera Markerless Motion Capture System https://news.medxy.ai/zh/troponin-pathway-reassessment/Medxy AIzh2026-11-13T03:59:19-08:000/1 小时心肌肌钙蛋白路径再评估：安全性获证实，但急诊停留时间并未缩短 https://news.medxy.ai/ja/troponin-algorithm-evaluation/Medxy AIja2026-11-13T03:59:04-08:000/1時間心筋トロポニン・アルゴリズムの評価：安全性は確認されたが救急外来滞在時間は短縮せず https://news.medxy.ai/vi/troponin-0-1-hour-protocol-review/Medxy AIvi2026-11-13T03:58:47-08:00Đánh giá quy trình troponin tim 0/1 giờ: Xác nhận an toàn nhưng không rút ngắn thời gian lưu tại khoa cấp cứu https://news.medxy.ai/evaluating-the-0-1-hour-cardiac-troponin-pathway-safety-confirmed-but-no-reduction-in-emergency-department-stay/Medxy AIen2026-11-13T03:58:33-08:00Evaluating the 0/1-Hour Cardiac Troponin Pathway: Safety Confirmed but No Reduction in Emergency Department Stay https://news.medxy.ai/zh/adolescent-sti-screening/Medxy AIzh2026-11-13T03:57:52-08:00提升青少年性传播感染筛查：一项覆盖多院区的沙眼衣原体和淋病奈瑟菌初级保健质量改进计划 https://news.medxy.ai/ja/improving-adolescent-sti-screening-2/Medxy AIja2026-11-13T03:57:37-08:00若年層における性感染症スクリーニングの向上：複数施設を対象とした、クラミジア・トラコマティスおよび淋菌に関するプライマリ・ケアの質改善プログラム https://news.medxy.ai/vi/improving-adolescent-sti-screening/Medxy AIvi2026-11-13T03:57:20-08:00Nâng cao sàng lọc STI ở thanh thiếu niên: Sáng kiến cải tiến chất lượng đa cơ sở trong chăm sóc ban đầu đối với Chlamydia và Gonorrhea https://news.medxy.ai/enhancing-adolescent-sti-screening-a-multisite-primary-care-quality-improvement-initiative-for-chlamydia-and-gonorrhea/Medxy AIen2026-11-13T03:57:05-08:00Enhancing Adolescent STI Screening: A Multisite Primary Care Quality Improvement Initiative for Chlamydia and Gonorrhea https://news.medxy.ai/zh/bone-quality-differences/Medxy AIzh2026-11-13T03:56:31-08:00类风湿关节炎与银屑病关节炎的骨质量差异：7年纵向HR-pQCT研究 https://news.medxy.ai/ja/bone-quality-differences-2/Medxy AIja2026-11-13T03:56:13-08:00関節リウマチと乾癬性関節炎で骨質への影響はどう異なるか：7年間のHR-pQCT縦断研究 https://news.medxy.ai/vi/disease-activity-bone-quality/Medxy AIvi2026-11-13T03:55:55-08:00Ảnh hưởng khác biệt của hoạt tính bệnh lên chất lượng xương ở viêm khớp dạng thấp và viêm khớp vảy nến: nghiên cứu HR-pQCT theo dõi dọc 7 năm https://news.medxy.ai/differential-impact-of-disease-activity-on-bone-quality-in-rheumatoid-and-psoriatic-arthritis-a-7-year-longitudinal-hr-pqct-study/Medxy AIen2026-11-13T03:55:39-08:00Differential Impact of Disease Activity on Bone Quality in Rheumatoid and Psoriatic Arthritis: A 7-Year Longitudinal HR-pQCT Study https://news.medxy.ai/zh/us-lung-transplant-data-disparities/Medxy AIzh2026-11-13T03:55:01-08:00美国肺移植候选者临床数据更新差异：对分配公平性的启示 https://news.medxy.ai/ja/intercenter-variation-in-lung-transplant-candidates/Medxy AIja2026-11-13T03:54:47-08:00米国肺移植候補者の臨床データ更新にみられるセンター間差と割り当て公平性への示唆 https://news.medxy.ai/vi/us-lung-transplant-data-disparities-2/Medxy AIvi2026-11-13T03:54:29-08:00Sự khác biệt trong việc cập nhật dữ liệu lâm sàng cho các ứng viên chờ ghép phổi tại Hoa Kỳ: Những hệ quả đối với sự công bằng trong phân bổ https://news.medxy.ai/assessing-center-level-variability-in-clinical-data-updates-for-us-lung-transplant-candidates-implications-for-allocation-equity/Medxy AIen2026-11-13T03:54:15-08:00Assessing Center-Level Variability in Clinical Data Updates for US Lung Transplant Candidates: Implications for Allocation Equity https://news.medxy.ai/zh/biologic-treatment-optimization/Medxy AIzh2026-11-13T03:53:39-08:00借助剂末效应优化化脓性汗腺炎生物制剂治疗：改善患者结局的新思路 https://news.medxy.ai/ja/optimizing-hidradenitis-suppurativa-treatment/Medxy AIja2026-11-13T03:53:21-08:00化膿性汗腺炎の生物学的製剤治療を最適化する：投与末期効果を活用して患者アウトカムを改善する https://news.medxy.ai/vi/biologic-treatment-optimization-2/Medxy AIvi2026-11-13T03:53:02-08:00Tối ưu hóa điều trị sinh học trong viêm tuyến mồ hôi mủ: Khai thác hiện tượng cuối liều để cải thiện kết cục cho bệnh nhân https://news.medxy.ai/optimizing-biologic-therapy-for-hidradenitis-suppurativa-harnessing-the-end-of-dose-effect-to-improve-patient-outcomes/Medxy AIen2026-11-13T03:52:47-08:00Optimizing Biologic Therapy for Hidradenitis Suppurativa: Harnessing the End-of-Dose Effect to Improve Patient Outcomes https://news.medxy.ai/zh/preoperative-endovascular-limb-salvage/Medxy AIzh2026-11-13T03:52:09-08:00术前经皮血管内介入如何助力下肢重建保肢 https://news.medxy.ai/ja/optimizing-limb-salvage/Medxy AIja2026-11-13T03:51:55-08:00下肢再建の肢温存を最適化するには：free tissue transferにおける術前経皮的血管内治療の役割 https://news.medxy.ai/vi/limb-salvage-optimization/Medxy AIvi2026-11-13T03:51:36-08:00Tối ưu hóa cứu chi: Vai trò của can thiệp nội mạch qua da trước phẫu thuật trong chuyển vạt mô tự do để tái tạo chi dưới https://news.medxy.ai/optimizing-limb-salvage-the-role-of-preoperative-percutaneous-endovascular-intervention-in-free-tissue-transfer-for-lower-extremity-reconstruction/Medxy AIen2026-11-13T03:51:22-08:00Optimizing Limb Salvage: The Role of Preoperative Percutaneous Endovascular Intervention in Free Tissue Transfer for Lower-Extremity Reconstruction https://news.medxy.ai/zh/family-satisfaction-icu-assessment-2/Medxy AIzh2026-11-13T03:50:40-08:00优化成人ICU的家属满意度评估：12项版FS-ICUshort量表的开发与验证 https://news.medxy.ai/ja/family-satisfaction-icu-assessment/Medxy AIja2026-11-13T03:50:23-08:00成人ICUにおける家族満足度評価を最適化する：12項目版FS-ICUshort調査の開発と検証 https://news.medxy.ai/vi/family-satisfaction-survey/Medxy AIvi2026-11-13T03:50:02-08:00Tối ưu hóa đo lường mức độ hài lòng của gia đình tại ICU người lớn: Phát triển và thẩm định bảng khảo sát FS-ICUshort 12 mục https://news.medxy.ai/optimizing-family-satisfaction-measurement-in-adult-icus-development-and-validation-of-the-12-item-fs-icushort-survey/Medxy AIen2026-11-13T03:49:45-08:00Optimizing Family Satisfaction Measurement in Adult ICUs: Development and Validation of the 12-Item FS-ICUshort Survey https://news.medxy.ai/zh/wearables-frailty-assessment-fairness/Medxy AIzh2026-11-13T03:49:00-08:00可穿戴技术与医院衰弱风险评分的融合：破解偏倚，推动衰弱评估公平化 https://news.medxy.ai/ja/wearable-frailty-assessment/Medxy AIja2026-11-13T03:48:46-08:00ウェアラブル技術とHospital Frailty Risk Scoreを統合する：フレイル評価におけるバイアス是正と公平性の推進 https://news.medxy.ai/vi/wearable-frailty-assessment-2/Medxy AIvi2026-11-13T03:48:27-08:00Tích hợp công nghệ thiết bị đeo với Hospital Frailty Risk Score: Giảm thiên lệch và thúc đẩy công bằng trong đánh giá yếu ớt https://news.medxy.ai/integrating-wearable-technology-with-hospital-frailty-risk-score-addressing-bias-and-promoting-equity-in-frailty-assessment/Medxy AIen2026-11-13T03:48:12-08:00Integrating Wearable Technology with Hospital Frailty Risk Score: Addressing Bias and Promoting Equity in Frailty Assessment https://news.medxy.ai/zh/cd20-car-t-waldenstrom-macroglobulinemia/Medxy AIzh2026-11-13T03:47:33-08:00CD20 靶向自体 CAR T 细胞治疗为难治性 Waldenström 巨球蛋白血症带来新希望 https://news.medxy.ai/ja/cd20-car-t-therapy-2/Medxy AIja2026-11-13T03:47:16-08:00BTKi不応性Waldenström macroglobulinemiaに挑むCD20標的自己CAR-T細胞療法 https://news.medxy.ai/vi/cd20-car-t-cell-therapy/Medxy AIvi2026-11-13T03:47:00-08:00Liệu pháp CAR T tự thân nhắm đích CD20: hướng điều trị mới đầy triển vọng cho Waldenström macroglobulinemia kháng trị https://news.medxy.ai/cd20-car-t-therapy/Medxy AIen2026-11-13T03:46:45-08:00Innovative CD20-Directed Autologous CAR T-Cell Therapy for Treatment-Refractory Waldenström Macroglobulinemia https://news.medxy.ai/patient-versus-surrogate-decision-making-for-life-sustaining-treatment-and-terminal-care-intensity/Medxy AIen2026-11-13T03:45:30-08:00Patient versus Surrogate Decision-Making for Life-Sustaining Treatment and Terminal Care Intensity https://news.medxy.ai/zh/electronic-behavioral-nudges-preoperative-testing-2/Medxy AIzh2026-11-13T03:44:53-08:00电子化行为干预能否减少低价值的术前检查：来自一项实用性随机临床试验的启示 https://news.medxy.ai/ja/can-digital-interventions-reduce-preoperative-testing/Medxy AIja2026-11-13T03:44:28-08:00電子的行動介入は低価値の術前検査を減らせるか：実用的ランダム化臨床試験からの示唆 https://news.medxy.ai/vi/electronic-behavioral-nudges-preoperative-testing/Medxy AIvi2026-11-13T03:44:02-08:00Tác động của các “nudges” hành vi điện tử lên xét nghiệm tiền phẫu giá trị thấp: Nhận định từ một thử nghiệm lâm sàng ngẫu nhiên thực dụng https://news.medxy.ai/effect-of-electronic-behavioral-nudges-on-low-value-preoperative-testing-insights-from-a-pragmatic-randomized-clinical-trial/Medxy AIen2026-11-13T03:43:41-08:00Effect of Electronic Behavioral Nudges on Low-Value Preoperative Testing: Insights from a Pragmatic Randomized Clinical Trial https://news.medxy.ai/zh/throat-cancer-microbes/Medxy AIzh2026-11-13T03:42:53-08:00喉癌微生物特征揭秘：聚焦 Parvimonas 与 Campylobacter 的新型治疗潜力 https://news.medxy.ai/ja/laryngeal-cancer-microbiome/Medxy AIja2026-11-13T03:42:34-08:00喉頭がんの微生物シグネチャーを解き明かす：Parvimonas と Campylobacter を標的とした新規治療の可能性 https://news.medxy.ai/vi/microbes-laryngeal-cancer/Medxy AIvi2026-11-13T03:42:16-08:00Giải mã dấu ấn vi sinh vật trong ung thư thanh quản: Parvimonas và Campylobacter như đích điều trị mới https://news.medxy.ai/unveiling-microbial-signatures-in-laryngeal-cancer-targeting-parvimonas-and-campylobacter-for-novel-therapeutics/Medxy AIen2026-11-13T03:42:01-08:00Unveiling Microbial Signatures in Laryngeal Cancer: Targeting Parvimonas and Campylobacter for Novel Therapeutics https://news.medxy.ai/zh/liver-transplantation-combined-cancer/Medxy AIzh2026-11-13T03:41:13-08:00重新审视合并性肝细胞-胆管癌的肝移植：精选患者的疗效可与肝细胞癌相媲美 https://news.medxy.ai/ja/rethinking-liver-transplantation/Medxy AIja2026-11-13T03:40:54-08:00複合型肝細胞・胆管癌に対する肝移植を再考する：選択症例では肝細胞癌に匹敵する成績 https://news.medxy.ai/vi/liver-transplantation-combined-cancer-2/Medxy AIvi2026-11-13T03:40:30-08:00Đánh giá lại ghép gan cho ung thư biểu mô tế bào gan–ung thư đường mật phối hợp: kết cục tương đương ung thư biểu mô tế bào gan ở nhóm bệnh nhân được chọn lọc https://news.medxy.ai/reevaluating-liver-transplantation-for-combined-hepatocellular-cholangiocarcinoma-comparable-outcomes-to-hepatocellular-carcinoma-in-selected-patients/Medxy AIen2026-11-13T03:40:12-08:00Reevaluating Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: Comparable Outcomes to Hepatocellular Carcinoma in Selected Patients https://news.medxy.ai/zh/urge-incontinence-phenotypes/Medxy AIzh2026-11-13T03:39:19-08:00急迫性尿失禁的生理分型：基于聚类分析识别三种不同表型 https://news.medxy.ai/ja/understanding-urge-incontinence/Medxy AIja2026-11-13T03:38:56-08:00切迫性尿失禁を読み解く：クラスター解析で見えた異なる生理学的表現型 https://news.medxy.ai/vi/urgent-urinary-incontinence-phenotypes/Medxy AIvi2026-11-13T03:38:36-08:00Giải mã tiểu không tự chủ cấp bách: Nhận diện các kiểu hình sinh lý khác nhau bằng phân tích cụm https://news.medxy.ai/decoding-urgency-urinary-incontinence-identifying-distinct-physiological-phenotypes-via-cluster-analysis/Medxy AIen2026-11-13T03:38:20-08:00Decoding Urgency Urinary Incontinence: Identifying Distinct Physiological Phenotypes via Cluster Analysis https://news.medxy.ai/zh/elafibranor-pbc-alp-normalization/Medxy AIzh2026-11-13T03:37:38-08:00Elafibranor助力原发性胆汁性胆管炎ALP正常化：来自III期ELSPIRE试验及相关研究的综合证据 https://news.medxy.ai/ja/elafibranor-pbc-treatment/Medxy AIja2026-11-13T03:37:19-08:00UDCA不十分反応の原発性胆汁性胆管炎に対する第二選択治療としてのElafibranor――第III相ELSPIRE試験と関連研究からみたALP正常化の意義 https://news.medxy.ai/vi/elafibranor-pbc-alp-normalization-elspire/Medxy AIvi2026-11-13T03:36:58-08:00Elafibranor thúc đẩy quá trình bình thường hóa nồng độ ALP trong bệnh viêm đường mật nguyên phát: Bằng chứng toàn diện từ thử nghiệm giai đoạn III ELSPIRE và các nghiên cứu liên quan https://news.medxy.ai/elafibranor-as-an-effective-second-line-treatment-to-normalize-alkaline-phosphatase-in-primary-biliary-cholangitis-with-incomplete-response-to-ursodeoxycholic-acid/Medxy AIen2026-11-13T03:36:40-08:00Elafibranor as an Effective Second-Line Treatment to Normalize Alkaline Phosphatase in Primary Biliary Cholangitis with Incomplete Response to Ursodeoxycholic Acid: Synthesizing Evidence from the Phase III ELSPIRE Trial and Related Studies https://news.medxy.ai/zh/multiple-sclerosis-ris-revised-criteria/Medxy AIzh2026-11-13T03:35:51-08:00RIS中的多发性硬化能更早识别：2024年 McDonald 标准修订带来的新启示 https://news.medxy.ai/ja/early-ms-diagnosis-imaging-2/Medxy AIja2026-11-13T03:35:34-08:00RISにおける多発性硬化症のより早期の特定：2024年マクドナルド診断基準改訂がもたらす新たな示唆 https://news.medxy.ai/vi/early-ms-diagnosis-imaging/Medxy AIvi2026-11-13T03:35:13-08:00Chẩn đoán sớm xơ cứng rải rác ở hội chứng biệt lập trên hình ảnh: Những điểm mới từ bản sửa đổi tiêu chuẩn McDonald 2024 https://news.medxy.ai/early-diagnosis-of-multiple-sclerosis-in-radiologically-isolated-syndrome-insights-from-2024-mcdonald-criteria-revisions/Medxy AIen2026-11-13T03:34:56-08:00Early Diagnosis of Multiple Sclerosis in Radiologically Isolated Syndrome: Insights from 2024 McDonald Criteria Revisions https://news.medxy.ai/zh/vitamin-d-scoliosis-bone-health/Medxy AIzh2026-11-13T03:34:11-08:00维生素D缺乏对青少年特发性脊柱侧弯骨健康的影响：一项6年前瞻性研究的启示 https://news.medxy.ai/ja/vitamin-d-scoliosis-bone-health-3/Medxy AIja2026-11-13T03:33:48-08:00思春期特発性脊柱側弯症におけるビタミンD欠乏と骨健康への影響：6年間前向き研究からの知見 https://news.medxy.ai/vi/vitamin-d-scoliosis-bone-health-2/Medxy AIvi2026-11-13T03:33:28-08:00Ảnh hưởng của thiếu hụt vitamin D lên sức khỏe xương trong vẹo cột sống vô căn ở tuổi vị thành niên: Những phát hiện từ nghiên cứu tiến cứu 6 năm https://news.medxy.ai/impact-of-vitamin-d-deficiency-on-bone-health-in-adolescent-idiopathic-scoliosis-insights-from-a-6-year-prospective-study/Medxy AIen2026-11-13T03:33:11-08:00Impact of Vitamin D Deficiency on Bone Health in Adolescent Idiopathic Scoliosis: Insights from a 6-Year Prospective Study https://news.medxy.ai/zh/biomarker-based-takotsubo-score/Medxy AIzh2026-11-13T03:32:30-08:00基于生物标志物识别Takotsubo综合征：BioTAK评分的开发与验证 https://news.medxy.ai/ja/detecting-takotsubo-syndrome/Medxy AIja2026-11-13T03:32:08-08:00冠動脈造影前にたこつぼ症候群を見分ける――BioTAKスコアの開発と検証 https://news.medxy.ai/vi/biotak-takotsubo-diagnosis/Medxy AIvi2026-11-13T03:31:45-08:00BioTAK: Bước tiến chẩn đoán hội chứng Takotsubo dựa trên biomarker https://news.medxy.ai/biomarker-based-diagnosis-of-takotsubo-syndrome-development-and-validation-of-the-biotak-score/Medxy AIen2026-11-13T03:31:24-08:00Biomarker-Based Diagnosis of Takotsubo Syndrome: Development and Validation of the BioTAK Score https://news.medxy.ai/zh/poorly-differentiated-thyroid-cancer-staging/Medxy AIzh2026-11-13T03:30:12-08:00分化不良甲状腺癌TNM分期全球方案：预后分层的新范式 https://news.medxy.ai/ja/international-tnm-staging-proposal/Medxy AIja2026-11-13T03:29:50-08:00低分化甲状腺癌のTNM病期分類に向けた国際提案：予後層別化を変える新たな枠組み https://news.medxy.ai/vi/global-tnm-staging-thyroid-cancer/Medxy AIvi2026-11-13T03:29:31-08:00Đề xuất toàn cầu về hệ thống TNM cho ung thư tuyến giáp biệt hóa kém: Bước ngoặt trong phân tầng tiên lượng https://news.medxy.ai/global-proposal-for-the-tnm-staging-system-for-poorly-differentiated-thyroid-cancer-a-paradigm-shift-in-prognostic-stratification/Medxy AIen2026-11-13T03:29:05-08:00Global Proposal for the TNM Staging System for Poorly Differentiated Thyroid Cancer: A Paradigm Shift in Prognostic Stratification https://news.medxy.ai/zh/acetabular-rim-microfracture/Medxy AIzh2026-11-13T03:28:15-08:00髋臼缘微骨折如何增强髋关节盂唇重建：来自猪模型的研究启示 https://news.medxy.ai/ja/enhancing-labral-reconstruction/Medxy AIja2026-11-13T03:27:58-08:00寛骨臼縁マイクロフラクチャーで股関節唇再建を強化する：ブタモデルからの知見 https://news.medxy.ai/vi/acetabular-rim-microfracture-enhancing-labral-reconstruction/Medxy AIvi2026-11-13T03:27:36-08:00Tăng cường tái tạo sụn viền khớp háng bằng kỹ thuật vi gãy xương viền ổ cối: Những hiểu biết từ mô hình lợn https://news.medxy.ai/enhancing-hip-labral-reconstruction-with-acetabular-rim-microfracture-insights-from-a-porcine-model/Medxy AIen2026-11-13T03:27:21-08:00Enhancing Hip Labral Reconstruction with Acetabular Rim Microfracture: Insights from a Porcine Model https://news.medxy.ai/zh/malnutrition-amputation-outcomes/Medxy AIzh2026-11-13T03:26:42-08:00营养不良如何影响缺血性血管疾病所致大下肢截肢后的结局：一项纵向研究的启示 https://news.medxy.ai/ja/malnutrition-amputation-outcomes-3/Medxy AIja2026-11-13T03:26:23-08:00血行障害性大切断後の低栄養が転帰に及ぼす影響：縦断研究からみた知見 https://news.medxy.ai/vi/malnutrition-amputation-outcomes-2/Medxy AIvi2026-11-13T03:26:05-08:00Tác động của suy dinh dưỡng đến kết cục sau cắt cụt chi dưới lớn do bệnh lý mạch máu: Những phát hiện từ một nghiên cứu theo dõi dọc https://news.medxy.ai/impact-of-undernutrition-on-outcomes-after-dysvascular-major-lower-limb-amputation-insights-from-a-longitudinal-study/Medxy AIen2026-11-13T03:25:49-08:00Impact of Undernutrition on Outcomes After Dysvascular Major Lower Limb Amputation: Insights from a Longitudinal Study https://news.medxy.ai/zh/individualized-osteoradionecrosis-risk/Medxy AIzh2026-11-13T03:25:09-08:00放疗前拔牙对头颈癌骨放射性坏死风险的个体化影响：来自因果机器学习的证据 https://news.medxy.ai/ja/individualized-osteoradionecrosis-risk-machine-learning/Medxy AIja2026-11-13T03:24:50-08:00頭頸部がんにおける放射線治療前の抜歯が骨放射線壊死リスクに及ぼす個別の影響：因果機械学習によるエビデンス https://news.medxy.ai/vi/tooth-extraction-radiation-risk/Medxy AIvi2026-11-13T03:24:26-08:00Nhổ răng trước xạ trị ở bệnh ung thư đầu cổ: tác động cá thể hóa lên nguy cơ hoại tử xương do tia xạ https://news.medxy.ai/personalized-impact-of-pre-radiotherapy-tooth-extraction-on-osteoradionecrosis-risk-in-head-and-neck-cancer-insights-from-causal-machine-learning/Medxy AIen2026-11-13T03:24:09-08:00Personalized Impact of Pre-Radiotherapy Tooth Extraction on Osteoradionecrosis Risk in Head and Neck Cancer: Insights from Causal Machine Learning https://news.medxy.ai/zh/ct-coronary-angiography/Medxy AIzh2026-11-13T03:23:26-08:00急性胸痛排除心肌梗死后：门诊CT冠状动脉造影是否真的有用？ https://news.medxy.ai/ja/outpatient-ct-coronary-angiography/Medxy AIja2026-11-13T03:23:08-08:00急性胸痛に対する外来CT冠動脈造影の意義：心筋梗塞除外後の検証 https://news.medxy.ai/evaluating-outpatient-ct-coronary-angiography-in-acute-chest-pain-post-myocardial-infarction-rule-out/Medxy AIen2026-11-13T03:22:31-08:00Evaluating Outpatient CT Coronary Angiography in Acute Chest Pain Post-Myocardial Infarction Rule-Out https://news.medxy.ai/nurse-practitioner-led-pathway-slashes-specialist-wait-times-by-75-for-high-risk-liver-disease-patients/Medxy AIen2026-11-12T14:26:26-08:00Nurse Practitioner-Led Pathway Slashes Specialist Wait Times by 75% for High-Risk Liver Disease Patients